Product List - 28 - Page 572 - Chemicalbook

ChemicalBook

Chinese

Germany

Japanese

Korean

(2S)-2-[[(4S)-5-Cyclohexyl-2,2-difluoro-4-[[(8-isobutyl-6-phenyl-1,2,4-triazolo[4,3-a]pyrazin-3-yl)acetyl]amino]-3-oxopentanoyl]amino]-4-methyl-N-(2-pyrimidinylmethyl)valeramide

[1S,2S,(-)]-1,2-Cyclohexanedimethanol

(4S,5S)-6-Cyclohexyl-5-[[(2R,4R,5S)-6-phenyl-5-(benzyloxycarbonylamino)-4-hydroxy-2-pentylhexanoyl]amino]-4-hydroxy-2-methylene-N-(2-methylpropyl)hexanamide

(4S,5S)-6-Cyclohexyl-5-[2-[[(2S)-2-(benzyloxycarbonylamino)-3-phenylpropionyl]amino]-6-heptenoylamino]-4-hydroxy-2-methylene-N-(2-methylpropyl)hexanamide

(1S,2S)-2-CYCLOPROPYLAMINO CYCLOHEXANOL

(S,S)-5-CYCLOOCTENE-1,2-DIOL

(1S,4S)-2-CYCLOPENTYLMETHYL-2,5-DIAZA-BICYCLO[2.2.1]HEPTANE

(1S,4S)-(+)-2-CYCLOPENTYLMETHYL-2,5-DIAZA-BICYCLO[2.2.1]HEPTANE DIHYDROCHLORIDE

(1S,2S)-(-)-[1,2-CYCLOHEXANEDIAMINO-N,N'-BIS(3,5-DI-T-BUTYLSALICYLIDENE)]CHROMIUM(III)CHLORIDE

(S,S)-(+)-1,2-CYCLODODECANEDIOL

(1S,2S)-(+)-[1,2-CYCLOHEXANEDIAMINO-N N'-BIS(3,5-DI-T-BUTYLSALICYLIDENE)]ALUMINUM (III) CHLORIDE

(4S,5S,αE,α'E)-2,2-Dimethyl-1,3-dioxolane-4,5-bis(acrylic acid methyl) ester

(3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid

(1S,1'S)-4,4'-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonene-1,18-diyl]bis(2-oxo-3,5,5-trimethyl-3-cyclopentene-1-carboxylic acid)

(6S,7S,10E,14E,18E)-6,7-Epoxy-2,6,10,15,19,23-hexamethyl-2,10,14,18,22-tetracosapentene

5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one

(1S,2S,3E,7E)-2-Hydroxy-4,8,12-trimethyl-β-methylenecyclotetradeca-3,7,11-triene-1-ethanol

(1S,5R)-N,N,6,6-Tetramethylbicyclo[3.1.1]heptan-3β-amine oxide

(3S,4S,7E,11E)-3-(Methoxymethyl)-4-(methoxycarbonyl)-7,11-dimethylcyclotetradeca-7,11-diene-1-acetic acid methyl ester

(3S,4R)-8-Nonene-3,4-diol

(S,R)-N-(1-Phenylethyl) Ibuprofen AMide

(1S,5R)-N-Phenyl-8-oxabicyclo[3.2.1]oct-6-en-3α-amine

(1S,4R)-2α-Norbornanecarboxylic acid ethyl ester

(1S,5R)-N-Phenyl-N-propionyl-8-oxabicyclo[3.2.1]oct-6-en-3α-amine

(1S,5R)-N-Phenyl-8-oxabicyclo[3.2.1]oct-6-en-3-imine

(1S,3S,4E)-4-[(2E)-2-[(1R,3aR,7aS)-1-[(E,2S)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-6-methylidene-cyclohexane-1,3-diol

D-(+)-Norephedrine

(1S,2S,4E,8E)-2,6,6,9-Tetramethyl-1-nitro-2-nitroso-4,8-cycloundecadiene

(1S,4S,7E,11E)-4-[2-(tert-Butyldimethylsiloxy)ethyl]-3-oxo-4,8,12-trimethylcyclotetradeca-7,11-diene-1-carbonitrile

S,S'-[(1E,3E)-1,2,3,4-Tetrachloro-1,3-butadiene-1,4-diyl]bis[N1-(carboxymethyl)-N2-(L-γ-glutamyl)-L-cysteinamide]

S,S'-[(1E,3E)-1,2,3,4-Tetrachloro-1,3-butadiene-1,4-diyl]bis(N-acetylcysteine)

(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one

(5S,6S,7E,9E,11Z,14Z)-5,6-Dihydroxy-7,9,11,14-icosatetraenoic acid

4-[(2S,3S)-3-[(1E,3E,5Z,8Z)-tetradeca-1,3,5,8-tetraenyl]oxiran-2-yl]butanoic acid

SSDP, vertebrate

(7S,9S,10E)-4,5,6,7,8,9-Hexahydro-9-acetoxy-3-(acetoxymethyl)-7-hydroxy-10-methyl-6-methylenecyclodeca[b]furan-2(11aαH)-one

(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-3-methyl-5,14,16-tris(trimethylsilyloxy)-1H-2-benzoxacyclotetradecin-1,7(8H)-dione

(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione

(1S,6S)-2-(β-D-Ribofuranosyl)-4-benzyl-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione

(1S,6S)-2-(β-D-Ribofuranosyl)-6-fluoro-4-benzyl-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione

(1S,6S)-2-(β-D-Ribofuranosyl)-6-fluoro-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione

(1S,6S)-2-(β-D-Ribofuranosyl)-4-ethyl-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione

(1S,6S)-2-(β-D-Ribofuranosyl)-6-fluoro-4-ethyl-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione

(1S,6S)-2-(β-D-Ribofuranosyl)-4,7,7,8,8-pentamethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione

(1S,6S)-2-(β-D-Ribofuranosyl)-6-fluoro-4,7,7,8,8-pentamethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione

1-SS-D-RIBOFURANOSE 1,2,3,5-TETRAACETATE

9-[SS-D-RIBOFURANOSYL]-2,6-DIAMINOPURINE

[S(R)]-N-[(4S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]-2-methyl-2-propanesulfinamide

(2S,3R)-N-[(3R,4S)-5,8-Dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14(1),15-tetren-4-yl]-2-(dimethylamino)-3-methylpentanamide

(2S,3R)-N-[(3R,4S,7S)-7-Benzoyl-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14(1),15-tetren-4-yl]-2-(dimethylamino)-3-methylpentanamide

(2S,3R)-N-tert-Butoxycarbonyl-3-benzoyloxy-2-pyrrolidinecarboxylic acid methyl ester

(2S,3R)-N-(tert-Butyloxycarbonyl)-3-Methyl-5-oxo-pyrrolidinecarboxylic Acid

(2S,3R)-N-(tert-Butyloxycarbonyl)-O-(tert-butyl)diMethylsilyl-3,4-dehydro-pyroglutaMinol

(2S,3R)-N-(tert-Butyloxycarbonyl)-3-Methyl-pyroglutaMinol

(4S,5S,E)-5-Hydroxy-4-[(tert-butyldimethylsilyl)oxy]-2-hexenoic acid ethyl ester

(4S,5S,E)-5-Hydroxy-4-[[(3,4,5,6-tetrahydro-2H-pyran)-2-yl]oxy]-2-hexenoic acid ethyl ester

(4S,5S)-6-[(E)-1-(Hydroxymethyl)ethylidene]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt

(4S,5S,E)-4-Hydroxy-5-[(tert-butyldimethylsilyl)oxy]-2-hexenoic acid ethyl ester

(3S,4R)-N-(TERT-BUTOXYCARBONYL)-4-AMINO-3-HYDROXY-5-PHENYLPENTANOIC ACID

(3S,4R)-N-(TERT-BUTOXYCARBONYL)-4-AMINO-3-HYDROXY-6-METHYLHEPTANOIC ACID

(1’S,2R)-2-[(1’,2’-O-Isopropylidene)dihydroxyethyl]-6-fluorochroman-4-one

(1S,2R)-N-TOSYLEPHEDRINE

[[[2S,6R]-6-[N-[Trifluoromethylcarbonyl]-N-[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]hexahydro-5-oxo-2-(2-thienyl)-1,4-thiazepin]-4-yl]acetic acid methyl ester

[[(2S,6R)-6-[N-(Trifluoromethylcarbonyl)-N-[(S)-1-(methoxycarbonyl)-3-(2,3,4,5,6-2H5)phenylpropyl]amino]hexahydro-5-oxo-2-(2-thienyl)-1,4-thiazepin]-4-yl]acetic acid methyl ester

[[[2S,6R]-6-[N-[Trifluoromethylcarbonyl]-N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]hexahydro-5-oxo-2-(2-thienyl)-1,4-thiazepin]-4-yl]acetic acid methyl ester

(S,R)-Palonosetron Hydrochloride

(2S,6R)-2-Palmitoylamino-6,7-di(palmitoyloxy)heptanoic acid benzyl ester

(2S,6R)-2-Palmitoylamino-6,7-di(palmitoyloxy)heptanoic acid

[S,(-)]-2,3'-Selenodipropionic acid

[S,(+)]-2-Selenocyanatopropionic acid potassium salt

[S,(+)]-2-Selenocyanatopropionic acid ethyl ester

SrpA protein, Pseudomonas

(S,S)-Duphos and BPE Rhodium Catalyst Kit for Asymmetric Hydrogenation

(S,S)-F-BINAPHANE

(S,S)-DUTHALER-HAFNER REAGENT

(2S,3S,4E)-2-Methyl-3-(trimethylsilyl)-4-hexenoic acid

(2S,3S,4E)-2-Methoxy-3-(trimethylsilyl)-4-hexenoic acid

(2S,3S,4E)-2-Methyl-3-[dimethyl(phenyl)silyl]-6-benzoyloxy-4-hexenoic acid

3S, 5S enantioMer of Atorvastatin CalciuM

s,s-endo-lurasidone HCl

SrpC protein, Pseudomonas

(2S,3R)-3-Pentyloxirane-2-methanol acetate

SS- Fenvalerate

2-[(2S,3R)-3-Pentyloxiran-2-yl]ethanol

(2S,8R)-2-Pentyl-8-propyloxocane

(2S,3R)-4-Pentene-1,2,3-triol

(17S,21S)-17,21-Epidioxy-17,21-epoxy-17,21-secohopane

22S,23S-EPICASTASTERONE

S-ropivacaine mesylate

(S)-ROPIVACAINE MSILATE

22S,23S-EPIBRASSINOLIDE

22S,23S-EPICASTASTERONE

(S)Ropivacaine Mesilate

568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672

Copyright 2007© ChemicalBook. All rights reserved.